Viewing Study NCT00279760


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2025-12-26 @ 12:27 AM
Study NCT ID: NCT00279760
Status: COMPLETED
Last Update Posted: 2016-09-16
First Post: 2006-01-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module